tetano
Editor, Senior Moderator
Adv Exp Med Biol. 2019 Dec 13. doi: 10.1007/5584_2019_454. [Epub ahead of print] [h=1]Virological and Epidemiological Situation in the Influenza Epidemic Seasons 2016/2017 and 2017/2018 in Poland.[/h]
Hallmann-Szelińska E[SUP]1[/SUP], Łuniewska K[SUP]2[/SUP], Szymański K[SUP]2[/SUP], Kowalczyk D[SUP]2[/SUP], Sałamatin R[SUP]3[/SUP], Masny A[SUP]2[/SUP], Brydak LB[SUP]2[/SUP].
[h=3]Author information[/h] 1 Department of Influenza Research - National Influenza Center, National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland. ehallmann@pzh.gov.pl. 2 Department of Influenza Research - National Influenza Center, National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland. 3 Department of General Biology and Parasitology, Warsaw Medical University, Warsaw, Poland.
[h=3]Abstract[/h] The World Health Organization estimates that influenza virus infects 3-5 million people worldwide every year, of whom 290,000 to 650,000 die. In the 2016/2017 epidemic season in Poland, the incidence of influenza was 1,692 per 100,000 population. The influenza A virus, subtype A/H3N2/, was the predominant one in that season. However, in the most recent 2017/2018 epidemic season, the incidence exceeded 1,782 per 100,000 already by August of 2018. In this season, influenza B virus predominated, while the A/H1N1/pdm09 strain was most frequent among the influenza A subtypes. The peak incidence, based on the number of clinical specimens tested, was in weeks 4-5 of 2017 and week 8 of 2018 in the 2016/2017 and 2017/2018 epidemic seasons, respectively. As of the 2017/2018 season, a quadrivalent vaccine, consisting of two antigens of influenza A subtypes and another two of influenza B virus, was available in Poland. Nonetheless, the vaccination rate remained at one of the lowest level in Europe, fluctuating between 3% and 4% of the general Polish population.
[h=4]KEYWORDS:[/h] Disease incidence; Epidemic season; Epidemiology; Infection; Influenza; Vaccination rate; Viral subtypes
PMID: 31832902 DOI: 10.1007/5584_2019_454
Hallmann-Szelińska E[SUP]1[/SUP], Łuniewska K[SUP]2[/SUP], Szymański K[SUP]2[/SUP], Kowalczyk D[SUP]2[/SUP], Sałamatin R[SUP]3[/SUP], Masny A[SUP]2[/SUP], Brydak LB[SUP]2[/SUP].
[h=3]Author information[/h] 1 Department of Influenza Research - National Influenza Center, National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland. ehallmann@pzh.gov.pl. 2 Department of Influenza Research - National Influenza Center, National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland. 3 Department of General Biology and Parasitology, Warsaw Medical University, Warsaw, Poland.
[h=3]Abstract[/h] The World Health Organization estimates that influenza virus infects 3-5 million people worldwide every year, of whom 290,000 to 650,000 die. In the 2016/2017 epidemic season in Poland, the incidence of influenza was 1,692 per 100,000 population. The influenza A virus, subtype A/H3N2/, was the predominant one in that season. However, in the most recent 2017/2018 epidemic season, the incidence exceeded 1,782 per 100,000 already by August of 2018. In this season, influenza B virus predominated, while the A/H1N1/pdm09 strain was most frequent among the influenza A subtypes. The peak incidence, based on the number of clinical specimens tested, was in weeks 4-5 of 2017 and week 8 of 2018 in the 2016/2017 and 2017/2018 epidemic seasons, respectively. As of the 2017/2018 season, a quadrivalent vaccine, consisting of two antigens of influenza A subtypes and another two of influenza B virus, was available in Poland. Nonetheless, the vaccination rate remained at one of the lowest level in Europe, fluctuating between 3% and 4% of the general Polish population.
[h=4]KEYWORDS:[/h] Disease incidence; Epidemic season; Epidemiology; Infection; Influenza; Vaccination rate; Viral subtypes
PMID: 31832902 DOI: 10.1007/5584_2019_454